The evolution of mathematical immunology

Immunological Reviews

Volumn 216, Issue 1, 2007, Pages 9-20

  Louzoun, Yoram ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Mathematical modeling; Systems immunology; Theoretical immunology

Indexed keywords

BIOINFORMATICS; EPIGENETICS; GENOMICS; HIGH THROUGHPUT SCREENING; IMMUNOGENETICS; IMMUNOLOGY; INNATE IMMUNITY; MATHEMATICAL MODEL; MOLECULAR EVOLUTION; MONTE CARLO METHOD; PRIORITY JOURNAL; REVIEW; SIMULATION; THEORETICAL MODEL;

ANIMALS; COMPUTATIONAL BIOLOGY; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY; MICE; MODELS, IMMUNOLOGICAL;

EID: 33947283687     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2006.00495.x     Document Type: Review

References (140)

1. Groves DL, Lever WE, Makinodan T. Stochastic model for the productionof antibody-forming cells. Nature 1969;222:95-97.
2. Marchalonis JJ, Gledhill VX. Elementary stochastic model for the induction of immunity and tolerance. Nature 1968;220:608-611.
3. Bell GI. Mathematical model of clonal selection and antibody production. 3. The cellular basis of immunological paralysis. J Theor Biol 1971;33:378-398.
4. Cristea A. [A mathematical model of the development of an apparent infection with applications to the study of the process of immunization]. Rev Roum Inframicrobiol 1971;8:15-26.
5. Hiramoto RN, Ghanta VK, McGhee JR, Hamlin NM. A mathematical model for the quantitation of tumor and antibody-forming cell populations within an animal's body. J Immunol 1973;111:1546-1553.
6. Levi MI, Basova NN, Durikhin KV. Cyclic kinetics and mathematical expression of the primary immune response of soluble antigen. IV. Response of the organism to the injection of two substances with plasma cell activity. Folia Microbiol (Praha) 1973;18:315-318.
7. Hoffmann GW. A theory of regulation and self-nonself discrimination in an immune network. Eur J Immunol 1975;5:638-647.
8. Perelson AS, Mirmirani M, Oster GF. Optimal strategies in immunology. I. B-cell differentiation and proliferation. J Math Biol 1976;3:325-367.
9. Streilein JW, Read CB. A mathematical model in immunoregulation where the spleen has a pivotal role. J Theor Biol 1976;61:363-376.
10. Larson EW, Dominik JW, Rowberg AH, Higbee GA. Influenza virus population dynamics in the respiratory tract of experimentally infected mice. Infect Immun 1976;13:438-447.
11. Dibrov BF, Livshits MA, Volkenstein MV. Mathematical model of immune processes. II. Kinetic features of antigen-antibody interrelations. J Theor Biol 1977;69:23-39.
12. Mitchison NA. Mathematical models in immunology. Nature 1978;275:675-676.
13. Dietz K. Epidemiologic interference of virus populations. J Math Biol 1979;8:291-300.
14. Ishkov VL, Lishchuk VA. [Mathematical models of immune processes]. Usp Sovrem Biol 1979;87:229-244.
15. Perelson AS, Wiegel FW. Theoretical considerations of the role of antigen structure in B cell activation. Fed Proc 1981;40:1479-1483.
16. Asquith B, Bangham CR. An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis. Proc Biol Sci 2003;270:1651-1657.
17. Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses. Science 1996;272:74-79.
18. Allen AD. Modeling AIDS and its treatment with immunostimulation. Med Hypotheses 1988;26:55-58.
19. Jacobs MJ, van den Hoek AE, van de Putte LB, van den Berg WB. Induction of tolerance by T-cell vaccination is possible beyond the area of autoimmunity: down-regulation of immunity directed to foreign protein antigens. Immunology 1993;80:511-517.
20. Khan QJ, Greenhalgh D. Hopf bifurcation in epidemic models with a time delay in vaccination. IMA J Math Appl Med Biol 1999;16:113-142.
21. McLean AR, Blower SM. Modelling HIV vaccination. Trends Microbiol 1995;3:458-462.
22. Mossong J, Muller CP. Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine 2003;21:4597-4603.
23. Nowak MA, McLean AR. A mathematical model of vaccination against HIV to prevent the development of AIDS. Proc Biol Sci 1991;246:141-146.
24. Iber D, Maini PK. A mathematical model for germinal centre kinetics and affinity maturation. J Theor Biol 2002;219:153-175.
25. Kesmir C, De Boer RJ. A mathematical model on germinal center kinetics and termination. J Immunol 1999;163:2463-2469.
26. Meyer-Hermann M. A mathematical model for the germinal center morphology and affinity maturation. J Theor Biol 2002;216:273-300.
27. Bhanot G. Results from modeling of B-Cell receptors binding to antigen. Prog Biophys Mol Biol 2004;85:343-352.
28. Dintzis HM, Dintzis RZ, Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci USA 1976;73:3671-3675.
29. Sulzer B, Perelson AS. Immunons revisited: binding of multivalent antigens to B cells. Mol Immunol 1997;34:63-74.
30. Sulzer B, Perelson AS. Equilibrium binding of multivalent ligands to cells: effects of cell and receptor density. Math Biosci 1996;135:147- 185.
31. Jerne NK. Clonal selection in a lymphocyte network. Soc Gen Physiol Ser 1974;29:39-48.
32. Jerne NK. The immune system: a web of V-domains. Harvey Lect 1974;70(Series):93-110.
33. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125C:373-389.
34. Jerne NK, Henry C, Nordin AA, Fuji H, Koros AM, Lefkovits I. Plaque forming cells: methodology and theory. Transplant Rev 1974;18:130-191.
35. Vaz NM, Varela FJ. Self and non-sense: an organism-centered approach to immunology. Med Hypotheses 1978;4:231-267.
36. Urbain J, et al. Idiotypic networks and self-recognition in the immune system. Ann Immunol (Paris) 1979;130:281-291.
37. Nicholls EM. The evolution of an immune system. Med Hypotheses 1979;5:225-235.
38. Roitt IM, et al. Idiotypic networks and their possible exploitation for manipulation of the immune response. Lancet 1981;1:1041-1045.
39. Hiernaux J. Antiidiotypic networks. Fed Proc 1981;40:1484-1488.
40. Urbain J, Wuilmart C, Cazenave PA. Idiotypic regulation in immune networks. Contemp Top Mol Immunol 1981;8:113-148.
41. Perelson AS. Immune network theory. Immunol Rev 1989;110:5-36.
42. Varela FJ, Coutinho A. Immune networks: getting on to the real thing. Res Immunol 1989;140:837-845.
43. Atlan H. Automata network theories in immunology: their utility and their underdetermination. Bull Math Biol 1989;51:247-253.
44. Weisbuch G, De Boer RJ, Perelson AS. Localized memories in idiotypic networks. J Theor Biol 1990;146:483-499.
45. Varela FJ, Stewart J. Dynamics of a class of immune networks. I. Global stability of idiotype interactions. J Theor Biol 1990;144:93-101.
46. Stewart J, Varela FJ. Dynamics of a class of immune networks. II. Oscillatory activity of cellular and humoral components. J Theor Biol 1990;144:103-115.
47. Parisi G. A simple model for the immune network. Proc Natl Acad Sci USA 1990;87:429-433.
48. Stadler PF, Schuster P. Dynamics of small autocatalytic reaction networks - I. Bifurcations, permanence and exclusion. Bull Math Biol 1990;52:485-508.
49. Antia R, Levin B, Williamson P. A quantitative model suggests immune memory involves the colocalization of B and Th cells. J Theor Biol 1991;153:371-384.
50. Coutinho A. Size and connectivity: a bit of the history of immune networks. J Theor Biol 1991;149:425-427.
51. Lohse AW, Bakker NP, Hermann E, Poralla T, Jonker M, Meyer zum Buschenfelde KH. Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans. J Autoimmun 1993;6:121-130.
52. Brede M, Behn U. Architecture of idiotypic networks: percolation and scaling behavior. Phys Rev E Stat Nonlin Soft Matter Phys 2001;64:011908.
53. Mannie MD. Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells. Immunol Res 1999;19:65-87.
54. La Cava A, Van Kaer L, Fu Dong S. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol 2006;27:322-327.
55. Pendergraft WF 3rd, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004;10:72-79.
56. Langman RE. Molecular economy and antibody function: the evolution of a Protecton. Int J Clin Lab Res 1992;22:63-68.
57. Langman RE, Mata JJ, Cohn M. A computerized model for the self-non-self discrimination at the level of the T(h) (Th genesis). II. The behavior of the system upon encounter with non-self antigens. Int Immunol 2003;15:593- 609.
58. Fuchs EJ, Matzinger P. Is cancer dangerous to the immune system? Semin Immunol 1996;8:271-280.
59. Cohen IR, Mor F. On the regulation of EAE. Int Rev Immunol 1993;9:243-249.
60. Cohen IR. The cognitive paradigm and the immunological homunculus. Immunol Today 1992;13:490-494.
61. Cohen IR, Young DB. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991;12:105-110.
62. Wan S, Coveney PV, Flower DR. Peptide recognition by the T cell receptor: comparison of binding free energies from thermodynamic integration, Poisson-Boltzmann and linear interaction energy approximations. Philos Transact Ser A Math Phys Eng Sci 2005;363:2037-2053.
63. Gonzalez PA, et al. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci USA 2005;102:4824-4829.
64. Zhao Y, et al. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J Immunol 2001;167:2130-2141.
65. Metzger H, et al. A quantitative approach to signal transduction. Immunol Lett 1999;68:53-57.
66. Li Y, Louzoun Y, Weigert M. Editing anti-DNA B cells by Vlambdax. J Exp Med 2004;199:337-346.
67. Louzoun Y, Friedman T, Luning Prak E, Litwin S, Weigert M. Analysis of B cell receptor production and rearrangement. Part I. Light chain rearrangement. Semin Immunol 2002;14:169-190; discussion 221-222.
68. Louzoun Y, Luning Prak E, Litwin S, Weigert M. D is for different-differences between H and L chain rearrangement. Semin Immunol 2002;14:239-241.
69. Magori-Cohen R, Louzoun Y, Kleinstein SH. Mutation parameters from DNA sequence data using graph theoretic measures on lineage trees. Bioinformatics 2006;22:e332-e340.
70. Kleinstein SH, Singh JP. Why are there so few key mutant clones? The influence of stochastic selection and blocking on affinity maturation in the germinal center. Int Immunol 2003;15:871-884.
71. Kleinstein SH, Louzoun Y, Shlomchik MJ. Estimating hypermutation rates from clonal tree data. J Immunol 2003;171:4639-4649.
72. Sekiguchi DR, et al. Development and selection of edited B cells in B6.56R mice. J Immunol 2006;176:6879-6887.
73. Li Y, Li H, Ni D, Weigert M. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J Exp Med 2002;196:1543- 1552.
74. Chen C, Li H, Tian Q, Beardall M, Xu Y, Casanova N, Weigert M. Selection of antidouble-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J Immunol 2006;176:5183-5190.
75. Bernaschi M, Succi S, Castiglione F. Large-scale cellular automata simulations of the immune system response. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 2000;61:1851-1854.
76. Celada F, Seiden PE. Affinity maturation and hypermutation in a simulation of the humoral immune response. Eur J Immunol 1996;26:1350- 1358.
77. Celada F, Seiden PE. A computer model of cellular interactions in the immune system. Immunol Today 1992;13:56-62.
78. Morpurgo D, Serentha R, Seiden PE, Celada F. Modelling thymic functions in a cellular automaton. Int Immunol 1995;7:505-516.
79. Seiden PE, Celada F. A model for simulating cognate recognition and response in the immune system. J Theor Biol 1992;158:329-357.
80. Kohler B, Puzone R, Seiden PE, Celada F. A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system. I. Viral characteristics and polarized responses. Vaccine 2000;19:862- 876.
81. Farmer JD, Kauffman SA, Packard NH, Perelson AS. Adaptive dynamic networks as models for the immune system and autocatalytic sets. Ann NY Acad Sci 1987;504:118-131.
82. De Boer RJ, Perelson AS. T cell repertoires and competitive exclusion. J Theor Biol 1994;169:375-390.
83. Sulzer B, De Boer RJ, Perelson AS. Cross-linking reconsidered: binding and cross-linking fields and the cellular response. Biophys J 1996;70:1154-1168.
84. Meier-Schellersheim M. What is Simmune? Available at http://unith.desy. de/research/complex/immunology/software/index_eng.html, 2005.
85. Meier-Schellersheim M, Mack G. SIMMUNE, a tool for simulating and analyzing immune system behavior. Available at http://arxivorg/abs/csMA/9903017, 1999.
86. Pappalardo F, Lollini PL, Castiglione F, Motta S. Modeling and simulation of cancer immunoprevention vaccine. Bioinformatics 2005;21:2891-2897.
87. Motta S, Castiglione F, Lollini P, Pappalardo F. Modelling vaccination schedules for a cancer immunoprevention vaccine. Immunome Res 2005;1:5.
88. Al-Ubaydli M. Handheld Computers for Doctors. New Jersey: Wiley, 2003.
89. Efroni S, Harel D, Cohen IR. Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation. Genome Res 2003;13:2485-2497.
90. Li QJ, et al. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat Immunol 2004;5:791- 799.
91. Nudelman G, Louzoun Y. The role of lipid rafts in cell surface BCR antigen binding dynamics. EMBC 2004. Conference Proceedings, 26th Annual International Conference of the Engineering in Medicine and Biology Society.
92. Nudelman G, Louzoun Y. Cell surface dynamics: the balance between diffusion, aggregation and endocytosis. Syst Biol (Stevenage) 2006;153:34-42.
93. Chakraborty A. How and why does the immunological synapse form? Physical chemistry meets cell biology. Sci STKE 2002;2002:PE10.
94. Kleinstein SH, Singh JP. Toward quantitative simulation of germinal center dynamics: biological and modeling insights from experimental validation. J Theor Biol 2001;211:253-275.
95. Meyer-Hermann M, Beyer T. Conclusions from two model concepts on germinal center dynamics and morphology. Dev Immunol 2002;9:203-214.
96. Meyer-Hermann ME, Maini PK. Cutting edge: back to "one-way" germinal centers. J Immunol 2005;174:2489-2493.
97. Allen CD, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004;5:943-952.
98. Lefranc MP. Nomenclature of the human immunoglobulin kappa (IGK) genes. Exp Clin Immunogenet 2001;18:161-174.
99. Bromley SK, et al. The immunological synapse. Annu Rev Immunol 2001;19:375-396.
100. Monod MY, Giudicelli V, Chaume D, Lefranc MP. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 2004;20(Suppl.):I379-I385.
101. Ruiz M, Pallares N, Contet V, Barbi V, Lefranc MP. The human immunoglobulin heavy diversity (IGHD) and joining (IGHJ) segments. Exp Clin Immunogenet 1999;16:173-184.
102. Ruiz M, et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 2000;28:219-221.
103. Lefranc MP, et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1999;27:209-212.
104. Eason DD, Cannon JP, Haire RN, Rast JP, Ostrovd DA, Litman GW. Mechanisms of antigen receptor evolution. Semin Immunol 2004;16:215-226.
105. Schatz DG. Antigen receptor genes and the evolution of a recombinase. Semin Immunol 2004;16:245-256.
106. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol 2004;19:275-278.
107. Gay NJ, Gangloff M, Weber AN. Toll-like receptors as molecular switches. Nat Rev Immunol 2006;6:693-698.
108. Garcia-Penarrubia P, Bankhurst AD, Koster FT. Experimental and theoretical kinetics study of antibacterial killing mediated by human natural killer cells. J Immunol 1989;142:1310-1317.
109. Salmon-Divon M, Hoglund P, Johansson MH, Johansson S, Mehr R. Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A. Mol Immunol 2005;42:397-403.
110. Mehr R. Modeling the meta-dynamics of lymphocyte repertoires. Arch Immunol Ther Exp (Warsz) 2001;49:111-120.
111. Mehr R, Edelman H, Sehgal D, Mage R. Analysis of mutational lineage trees from sites of primary and secondary Ig gene diversification in rabbits and chickens. J Immunol 2004;172:4790-4796.
112. Mehr R, Shannon M, Litwin S. Models for antigen receptor gene rearrangement. I. Biased receptor editing in B cells: implications for allelic exclusion. J Immunol 1999;163:1793-1798.
113. Hakenberg J, et al. MAPPP: MHC class I antigenic peptide processing prediction. Appl Bioinformatics 2003;2:155-158.
114. Larsen MV, et al. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 2005;35:2295-2303.
115. Louzoun Y, Vider T, Weigert M. T-cell epitope repertoire as predicted from human and viral genomes. Mol Immunol 2006;43:559-569.
116. Mamitsuka H. Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models. Proteins 1998;33:460-474.
117. Margalit H, Altuvia Y. Insights from MHC-bound peptides. Novartis Found Symp 2003;254:77-90; discussion 91-101, 216-222, 250-252.
118. Peters B, et al. A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules. Vaccine 2005;23:5212-5224.
119. Reche PA, Zhang H, Glutting JP, Reinherz EL. EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology. Bioinformatics 2005;21:2140-2141.
120. Argyropoulos C, et al. Mining microarray data to identify transcription factors expressed in naive resting but not activated T lymphocytes. Genes Immun 2004;5:16-25.
121. Choi YL, et al. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions. Leukemia 2004;18:556-565.
122. Eriksson E, Forsgren A, Riesbeck K. Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis. J Leukoc Biol 2003;74:456-463.
123. Ji MJ, et al. Gene expression profile of CD4+ T cells reveals an interferon signaling suppression associated with progression of experimental Schistosoma japonicum infection. Cell Immunol 2003;224:55-62.
124. Johnson CD, et al. Genomic profiles and predictive biological networks in oxidant-induced atherogenesis. Physiol Genomics 2003;13:263-275.
125. Qin H, Yamada M, Tian L, Stewart DM, Gulino AV, Nelson DL. Tracking gene expression in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2003;3:437-442.
126. Rangel C, et al. Modeling T-cell activation using gene expression profiling and state-space models. Bioinformatics 2004;20:1361-1372.
127. Singh N, Bergman Y, Cedar H, Chess A. Biallelic germline transcription at the kappa immunoglobulin locus. J Exp Med 2003;197:743-750.
128. Quintana FJ, Hagedorn PH, Elizur G, Merbl Y, Domany E, Cohen IR. Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci USA 2004;101(Suppl.):14615-14621.
129. Lauwerys BR, Wakeland EK. Genetics of lupus nephritis. Lupus 2005;14:2-12.
130. Jorgensen TN, Gubbels MR, Kotzin BL. New insights into disease pathogenesis from mouse lupus genetics. Curr Opin Immunol 2004;16:787- 793.
131. Perelson AS, Goldstein B. Antigen modulation of antibody forming cells: the relationship between direct plaque size, antibody secretion rate and antibody affinity. J Immunol 1977;118:1649-1654.
132. Perelson AS, Goldstein B, Rocklin S. Optimal strategies in immunology III. The IgM-IgG switch. J Math Biol 1980;10:209-256.
133. Perelson AS, Delisi C, Siraganian RP. A method for determining whether the descending limb of a biphasic histamine release curve reflects insufficient cross-linking. Mol Immunol 1982;19:13-20.
134. De Boer RJ, Perelson AS, Kevrekidis IG. Immune network behavior - II. From oscillations to chaos and stationary states. Bull Math Biol 1993;55:781-816.
135. Nowak MA, May RM, Anderson RM. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. AIDS 1990;4:1095-1103.
136. Nowak MA, May RM. Mathematical biology of HIV infections: antigenic variation and diversity threshold. Math Biosci 1991;106:1-21.
137. Nowak MA, May RM. Coexistence and competition in HIV infections. J Theor Biol 1992;159:329-342.
138. McLean AR, Nowak MA. Models of interactions between HIV and other pathogens. J Theor Biol 1992;155:69-86.
139. Nowak MA. Variability of HIV infections. J Theor Biol 1992;155:1-20.
140. Nowak M, May RM. AIDS pathogenesis: mathematical models of HIV and SIV infections. AIDS 1993;7(Suppl.):S3-S18.